The action of DNA antagonists on Epstein-Barr virus (EBV)-associated early antigen (EA) in Burkitt lymphoma lines.
D000941:Antigens / Q000032:analysis*; D001345:Autoradiography; D002051:Burkitt Lymphoma / Q000276:immunology*; D002460:Cell Line; D003561:Cytarabine / Q000494:pharmacology*; D003597:Cytosine Nucleotides / Q000494:pharmacology; D004247:DNA / Q000037:antagonists & inhibitors*; D004279:DNA, Viral / Q000096:biosynthesis; D005455:Fluorescent Antibody Technique; D006564:Herpesviridae; D007065:Idoxuridine / Q000494:pharmacology*; D066298:In Vitro Techniques; D009303:Nasopharyngeal Neoplasms / Q000276:immunology; D011691:Puromycin / Q000494:pharmacology; D013936:Thymidine / Q000378:metabolism; D014316:Tritium
D000941:Antigens; D003597:Cytosine Nucleotides; D004279:DNA, Viral; D003561:Cytarabine; D014316:Tritium; D011691:Puromycin; D004247:DNA; D007065:Idoxuridine; D013936:Thymidine